: This specific mutation is the primary cause of Arrhythmogenic Right Ventricular Cardiomyopathy type 5 (ARVC5) , a highly aggressive cardiac disorder.
: Recent studies published in journals like Circulation Research explore gene therapies, such as using adeno-associated viruses (AAV) to deliver healthy versions of the protein to improve heart function. 3. Researcher Identifiers (ORCID) : This specific mutation is the primary cause
: It leads to the dilation of heart chambers and the replacement of healthy muscle with fibrofatty tissue, often resulting in sudden cardiac death. often resulting in sudden cardiac death.